Q4 2019 Holdings
Filed 2020-01-24 | 2 holdings | $79.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myovant Sciences Ltd. | COM | G637AM102 | $53.9K | 3,474,645 | 68.1% |
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $25.3K | 1,558,426 | 31.9% |